Mechanisms of cetuximab resistance in head and neck squamous cell Carcinoma: Focus on the EGFR-ERK pathway.
Combined targeting of ERK and EGFR may represent a promising strategy for overcoming cetuximab resistance in selected molecular contexts.
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Combined targeting of ERK and EGFR may represent a promising strategy for overcoming cetuximab resistance in selected molecular contexts.
It is reiterated the importance of genetic screening, tumor surveillance and tailored treatment approach in patients with germline pathogenic variants of head and neck paragangliomas.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.